27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Extract Labs, a Boulder, Colorado-based hemp extraction lab, recently announced it's funding cancer research being conducted at Colorado State University, at the James L. Voss Veterinary Teaching Hospital.
Specifically, researchers at CSU are conducting lab-based research on the impact of CBD against canine glioma, or brain and spinal cancer, cells. The research began in early 2019 to learn how CBD interacts with cancer cells, alone and in combination with a commonly used radiation therapy mechanism.
CBD has been shown to possess anti-tumor effects in human and rodent gliomas, and several studies demonstrate a similarity in canine and human gliomas. The initial phase of research is almost complete, and the team at Colorado State University hopes to publish study results within the next year.
“We are proud to be one of the few CBD companies in America currently funding canine cancer research through a university that is world-renowned for its medical care and research,” said Craig Henderson, founder of Extract Labs.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!